Isoray To Host Lunch Symposium At American Brachytherapy Society’s Annual Conference
June 15, 2022 08:10 ET
|
Isoray, Inc.
RICHLAND, Wash., June 15, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a lunch...
Isoray Announces Record Third Quarter Fiscal 2022 Financial Results
May 10, 2022 16:05 ET
|
Isoray, Inc.
Revenue Increased 12% Year-Over-YearRecord Non-Prostate Brachytherapy Revenue Increased 28% Year-Over-Year RICHLAND, Wash., May 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a...
Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022
April 29, 2022 08:05 ET
|
Isoray, Inc.
RICHLAND, Wash., April 29, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a...
Isoray to Participate in the Oppenheimer 32nd Annual Healthcare Conference
March 10, 2022 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., March 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy, today announced that Chief Executive Officer...
Study Finds Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray’s Cesium-131
March 02, 2022 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., March 02, 2022 (GLOBE NEWSWIRE) -- Investigators from the University of Pittsburgh School of Medicine have published a clinical study that demonstrates excellent outcomes for...
Isoray Announces Second Quarter Fiscal 2022 Financial Results
February 08, 2022 16:05 ET
|
Isoray, Inc.
Revenue Increased 19% Year-Over-YearProstate Brachytherapy Revenue Increased 13% Year-Over-Year RICHLAND, Wash., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical...
Isoray To Announce Second Quarter Fiscal 2022 Financial Results on February 8, 2022
January 26, 2022 08:10 ET
|
Isoray, Inc.
RICHLAND, Wash., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a conference...
Isoray Announces First Quarter Fiscal 2022 Financial Results
November 10, 2021 16:05 ET
|
Isoray, Inc.
Prostate Revenue Increased Year-Over-Year for Second Consecutive QuarterNon-Prostate Brachytherapy Revenue Increased 20% Year-Over-Year RICHLAND, Wash., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Isoray,...
Isoray To Announce First Quarter Fiscal 2022 Financial Results on November 10, 2021
October 29, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options...
American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Isoray’s Cesium-131
September 28, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., Sept. 28, 2021 (GLOBE NEWSWIRE) -- The American Brachytherapy Society (ABS) has recognized Isoray’s Cesium-131 in its recently released new consensus statement on the subject of low...